News
Glen Powell has revealed that his close friend, makeup artist Charlie Hounslow, has been diagnosed with stage 4 brain cancer.
Zongertinib shows promise for treating HER2-mutant non–small cell lung cancer (NSCLC), with significant activity against brain metastases and low interstitial lung disease risk, explains John Heymach, ...
Zongertinib elicited meaningful results in previously treated patients with HER2-mutated, advanced non–small cell lung cancer ...
21h
MedPage Today on MSNNovel TKI Highly Active in HER2-Mutant Lung CancerThe investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...
Zongertinib Shows Durable Responses With No Interstitial Lung Disease in HER2-Mutated Advanced NSCLC
Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...
Ingelheim, Germany Wednesday, April 30, 2025, 14:00 Hrs [IST] ...
In the Phase Ib Beamion LUNG-1 clinical trial, zongertinib, an investigational irreversible tyrosine kinase inhibitor, ...
1d
GlobalData on MSNBoehringer’s HER2-mutated lung cancer drug shows sustained benefit for 14 monthsBoehringer Ingelheim’s drug candidate for human epidermal growth factor receptor 2 (HER2)-mutated non-small cell lung cancer ...
Dizal will also present results from the ongoing Phase I/II study of DZD6008, a 4th generation EGFR TKI with full BBB penetration, in advanced EGFR mutation positive (EGFRm) non-small cell lung cancer ...
Cogent Biosciences (COGT) announced preclinical data from four pipeline programs during poster sessions at the American Association for Cancer ...
Drug Improves Effectiveness of Radiation for Lung Cancer That Has Spread to the Brain Oct. 4 ... New, Rare Type of Small Cell Lung Cancer Identified Sep. 11, 2024 — A team of doctors and ...
SAN FRANCISCO and SUZHOU,China, April 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results